Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5). | Front Pharmacol | 2023 | 38026988 | PubTator, text mining | PubMed |
| Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma. | Front Pharmacol | 2023 | 38026978 | PubTator, text mining | PubMed |
| Disturbance of Adaptive Immunity System Was Accompanied by a Decrease in Plasma Short-Chain Fatty Acid for Patients Hospitalized During SARS-CoV-2 Infection After COVID-19 Vaccination. | J Inflamm Res | 2023 | 38026252 | PubTator, text mining | PubMed |
| Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning. | Front Oncol | 2023 | 38023262 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing. | Front Immunol | 2023 | 38022625 | PubTator, text mining | PubMed |
| Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. | Front Immunol | 2023 | 38022534 | PubTator, text mining | PubMed |
| Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets. | Aging (Albany NY) | 2023 | 38019470 | PubTator, text mining | PubMed |
| CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade. | Res Sq | 2023 | 38014191 | PubTator, text mining | PubMed |
| Molecular and Cellular Mechanisms Underlying Neurologic Manifestations of Mosquito-Borne Flavivirus Infections. | Viruses | 2023 | 38005878 | PubTator, text mining | PubMed |
| Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types. | Biomedicines | 2023 | 38002057 | PubTator, text mining | PubMed |
| Whole Genome Expression Profiling of Semitendinosus Tendons from Children with Diplegic and Tetraplegic Cerebral Palsy. | Biomedicines | 2023 | 38001919 | PubTator, text mining | PubMed |
| ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer. | Nat Commun | 2023 | 37996458 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease. | Nat Commun | 2023 | 37968302 | PubTator, text mining | PubMed |
| Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. | Cell Rep Med | 2023 | 37967556 | PubTator, text mining | PubMed |
| HSP90AB1 Is a Host Factor Required for Transmissible Gastroenteritis Virus Infection. | Int J Mol Sci | 2023 | 37958953 | PubTator, text mining | PubMed |
| Cholinergic Polarization of Human Macrophages. | Int J Mol Sci | 2023 | 37958716 | PubTator, text mining | PubMed |
| Chemokines, molecular drivers of thromboinflammation and immunothrombosis. | Front Immunol | 2023 | 37954596 | PubTator, text mining | PubMed |
| Retracted: Comparative Study on the Clinical Efficacy and Safety of Acitretin and MTX in the Treatment of Pustular Psoriasis by TLR7/MyD88/CXCL16 Pathway. | Appl Bionics Biomech | 2023 | 37946840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=19